At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 48 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This registry collects information from people with atrial fibrillation (an irregular heart rhythm) who are having a procedure using the PulseSelect™ PFA System, a commercially available device. The study is run by Medtronic Cardiac Ablation Solutions.
Who can take part
- You are aged 18 or over, or the minimum age required by local rules
- You have been diagnosed with atrial fibrillation (an irregular heart rhythm)
- You are due to have a procedure using the PulseSelect™ PFA System, which is already available commercially
- You are willing to follow the study requirements and give informed consent (your documented, voluntary agreement to take part), or authorisation as required locally
Who may not be able to
- You are already taking part in another study that has not been approved for overlap by the global study manager
- You meet any exclusion criteria set by local law
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team (the registry does not say how many visits, how long it lasts, or what taking part involves).
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 1,950
- Started
- 2024-07-23
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for atrial fibrillation
- • Clinical study - 1,950 participants
- • The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with atrial fibrillation
Where?
- • Basildon - Basildon and Thurrock University Hospitals
- • Coventry - University Hospitals Coventry & Warwickshire
- • London - Saint Georges University Hospitals - NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
More detail
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-market registry. The purpose of this clinical study is to collect clinical performance and safety data in a broad patient population treated with the PulseSelect™ PFA system. The PulseSelect™ PFA System used in the study is market approved. The ablation procedure will be performed according to routine hospital practice. The follow up period is intended to align with standard practice and subjects will be followed for a minimum of 12 months post-procedure.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ by local regulations
What the study is looking for
- ✓Subject is ≥ 18 years of age or minimum age as required by local regulations.
- ✓Subject has been diagnosed with atrial fibrillation (AF)
- ✓Planned procedure using commercially available PulseSelect™ PFA System.
Who cannot take part
- ✗Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study...
- ✗Subject with exclusion criteria required by local law.
See the full criteria
Where Is This Study? (3 UK sites)
Basildon and Thurrock University Hospitals
Basildon SS16 5NL, United Kingdom
University Hospitals Coventry & Warwickshire
Coventry CV2 2DX, United Kingdom
Saint Georges University Hospitals - NHS Trust
London SW17 0QT, United Kingdom
How to Get in Touch
Josman Suri
Sponsor contactCONTACT